64 research outputs found
Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease
BACKGROUND: Liver biopsy is considered the gold standard for assessing histologic lesions of non-alcoholic fatty liver disease (NAFLD). The aim was to develop and validate a new biomarker of non alcoholic steato hepatitis (NASH) the NashTest (NT) in patients with NAFLD. METHODS: 160 patients with NAFLD were prospectively included in a training group, 97 were included in a multicenter validation group and 383 controls. Histological diagnoses used Kleiner et al's scoring system, with 3 classes for NASH: "Not NASH", "Borderline", "NASH"). The area under the ROC curves (AUROC), sensitivity (Se), specificity (Sp), and positive and negative predictive values (PPV, NPV) were assessed. RESULTS: NT was developed using patented algorithms combining 13 parameters: age, sex, height, weight, and serum levels of triglycerides, cholesterol, alpha2macroglobulin, apolipoprotein A1, haptoglobin, gamma-glutamyl-transpeptidase, transaminases ALT, AST, and total bilirubin. AUROCs of NT for the diagnosis of NASH in the training and validation groups were, respectively, 0.79 (95%CI 0.69â0.86) and 0.79 (95%CI 0.67â0.87; P = 0.94); for the diagnosis of borderline NASH they were: 0.69 (95%CI 0.60â0.77) and 0.69 (95%CI 0.57â0.78; P = 0.98) and for the diagnosis of no NASH, 0.77 (95%CI 0.68â0.84) and 0.83 (95%CI 0.67â0.90; P = 0.34). When the two groups were pooled together the NashTest Sp for NASH = 94% (PPV = 66%), and Se = 33% (NPV = 81%); for borderline NASH or NASH Sp = 50% (PPV = 74%) and Se = 88% (NPV = 72%). CONCLUSION: In patients with non-alcoholic fatty liver disease, NashTest, a simple and non-invasive biomarker reliably predicts the presence or absence of NASH
The importance of a Biosphere Reserve of Atlantic Forest for the conservation of stream fauna
Breast cancer stem cells: implications for therapy of breast cancer
The concept of cancer stem cells responsible for tumour origin, maintenance, and resistance to treatment has gained prominence in the field of breast cancer research. The therapeutic targeting of these cells has the potential to eliminate residual disease and may become an important component of a multimodality treatment. Recent improvements in immunotherapy targeting of tumour-associated antigens have advanced the prospect of targeting breast cancer stem cells, an approach that might lead to more meaningful clinical remissions. Here, we review the role of stem cells in the healthy breast, the role of breast cancer stem cells in disease, and the potential to target these cells
Behavior and major barriers faced by non-injectable drug users with HBV/HCV seeking treatment for hepatitis and drug addiction in Rio de Janeiro, Brazil
Identification of five bryozoan species in the Northern Mallee Pipeline, Australia
Five species of freshwater bryozoans were identified in the Northern Mallee Pipeline (NMP) system in Victoria, Australia, from statoblast morphology using scanning electron microscopy. The five species were Plumatella emarginata, Fredericella australiensis, Plumatella reticulata, Rumarcanella minuta and Fredericella sultana. The latter three of these have never previously been reported as occurring on the Australian continent and samples have been preserved for safekeeping at Victoria University. The statoblasts were isolated from samples collected as intact colonies from filters and membranes at a number of different locations
- âŠ